{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0052","upperLimit":"0.037","value":"0.016"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"313"}],"units":"Participants"}],"description":"Proportion of patients that had scleral invasion at enrollment.","dispersionType":"95% Confidence Interval","groups":[{"description":"This outcome measure is calculated by combining all groups as defined in the trials record.","id":"OG000","title":"All Patients"}],"paramType":"NUMBER","populationDescription":"Central review of the biological materials for this aim was available on only 313 patients. This outcome measure is calculated by combing all groups as characterized in the Patient Flow.","reportingStatus":"POSTED","timeFrame":"At enrollment","title":"Pathological Features Present at Diagnosis - Scleral Invasion (SI)","type":"SECONDARY","unitOfMeasure":"Proportion of patients with SI"}